Keywords: b-ms, orencia, performs, well, trials, usa-based, drug

B-MS's Orencia performs well in trials

Article | 15 May 2006

Print This

USA-based drug major Bristol-Myers Squibb says that data from trials of its drug Orencia (abatacept), in rheumatoid arthritis patients who ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in